locally advanced pancreas cancer
Showing 1 - 25 of >10,000
Radiotherapy - Comprehensive Radiobiology Assessment TRial
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 1, 2023
Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body
Not yet recruiting
- Pancreas Cancer
- +2 more
- Stereotactic Ablative Body Radiation (SABR)
- Tumor Treating Fields (TTF)
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
Survival, Quality of Life and Resectability in Locally Advanced
Recruiting
- Pancreas Cancer
- +8 more
-
Umeå, SwedenSurgical Clinic at Umeå University Hospital
Nov 23, 2022
Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Pancreas Adenocarcinoma
- +2 more
- Nab paclitaxel
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023
Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)
Not yet recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX treatment
- (no location specified)
Aug 9, 2023
Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Feb 10, 2022
Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable
Not yet recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +2 more
- Biospecimen Collection
- +8 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 9, 2023
Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)
Not yet recruiting
- Cancer
- +8 more
- DK210 (EGFR)
- +3 more
- (no location specified)
Jan 27, 2023
Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)
Recruiting
- Pancreatic Cancer
- Daily Adaptive External Beam Radiation Therapy
-
Saint Louis, MissouriWashington University, St. Louis
Mar 7, 2023
Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic
Recruiting
- Untreated Resectable Pancreatic Adenocarcinoma
- +2 more
- Paclitaxel protein bound
- +3 more
-
Scottsdale, ArizonaHonorHealth Research Institute
May 10, 2022
Resectable or Locally Advanced Borderline Pancreatic
Active, not recruiting
- Pancreas Cancer
- Adenocarcinoma
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Aug 19, 2022
Pancreatic Cancer Trial in France
Not yet recruiting
- Pancreatic Cancer
-
Amiens, France
- +22 more
Jul 20, 2022
Pancreas Cancer Trial in Wiener Neustadt (Particle-therapy using protons or carbon ions, Blood sampling, Magnetic resonance
Recruiting
- Pancreas Cancer
- Particle-therapy using protons or carbon ions
- +4 more
-
Wiener Neustadt, Niederösterreich, AustriaEBG MedAustron GmbH
Apr 7, 2022
Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)
Not yet recruiting
- Pancreatic Neoplasms
- +2 more
- BI 907828
- (no location specified)
Aug 22, 2022
Ductal Adenocarcinoma of the Pancreas Trial in Würzburg (Gem/nab-Pac, FOLFIFINOX)
Completed
- Ductal Adenocarcinoma of the Pancreas
-
Würzburg, Bayern, GermanyUniversitätsklinikum Würzburg/Comprehensive Cancer Center Mainfr
Dec 14, 2021
Pancreas Cancer Trial in Halle (Saale) (Visceral Debranching)
Recruiting
- Pancreas Cancer
- Visceral Debranching
-
Halle (Saale), GermanyUniversity Hospital, Dpt. of Visceral, Vascular and Endocrine Su
Sep 27, 2021
Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Scottsdale (Paclitaxel Protein
Active, not recruiting
- Resectable Pancreatic Cancer
- +3 more
- Paclitaxel Protein Bound (Abraxane)
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 15, 2022
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Biopsy
- +4 more
-
Chicago, Illinois
- +11 more
Jun 28, 2022
Metastatic Pancreas Cancer, Locally Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Worldwide (EndoTAG-1,
Completed
- Metastatic Pancreas Cancer
- +2 more
-
Corona, California
- +67 more
Apr 28, 2022
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Falimarev
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 4, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- DaRT seeds insertion
- (no location specified)
Sep 5, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
NSCLC, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer Trial in Boston (AGuIX, Radiotherapy)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- AGuIX
- Radiotherapy
-
Boston, Massachusetts
- +1 more
Oct 25, 2021